AusPAR: Certolizumab pegol
Australian Public Assessment Report
Device/Product Name
Cimzia
Active ingredients
Certolizumab pegol
AusPAR Date
Published
Sponsor
Submission Number
PM-2017-04943-1-1
Submission Type
Major variation; extension of indications
Decision
Approved